Interestingly, a single nucleotide variant in miR-1269a could reduce its own anticancer effect and even promote the occurrence and process of HCC by disinhibiting the oncogene LRP6 (Min et al., 2017) (Figure 1). The gene discussed is LRP6; the disease is hepatocellular carcinoma.